Radiation nephropathy after radiotherapy in metastatic medullary thyroid carcinoma

被引:23
作者
Stoffel, MP [1 ]
Pollok, M
Fries, J
Baldamus, CA
机构
[1] Univ Hosp Cologne, Dept Internal Med, Div Nephrol, D-50924 Cologne, Germany
[2] Univ Hosp Cologne, Inst Pathol, D-50924 Cologne, Germany
关键词
D O I
10.1093/ndt/16.5.1082
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:1082 / 1083
页数:2
相关论文
共 9 条
[1]  
Behr TM, 1997, CANCER-AM CANCER SOC, V80, P2591, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2591::AID-CNCR35>3.0.CO
[2]  
2-5
[3]  
Cohen EP, 2000, J PATHOL, V190, P484, DOI 10.1002/(SICI)1096-9896(200003)190:4<484::AID-PATH529>3.0.CO
[4]  
2-M
[5]   Mediators and mechanisms of radiation nephropathy [J].
Cohen, EP ;
Bonsib, SA ;
Whitehouse, E ;
Hopewell, JW ;
Robbins, MEC .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (02) :218-225
[6]  
HOPEWELL JW, 1986, BRIT J CANCER, V53, P181
[7]  
LUXTON RW, 1961, LANCET, V2, P1221
[8]   The lady who had a remote history of ovarian malignancy and developed thrombotic microangiopathy [J].
Moll, S ;
Pommer, W ;
Mihatsch, MJ ;
Nickeleit, V .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (03) :426-428
[9]   Yttrium-90-labelled somatostatin-analogue for cancer treatment [J].
Otte, A ;
Mueller-Brand, J ;
Dellas, S ;
Nitzsche, EU ;
Herrmann, R ;
Maecke, HR .
LANCET, 1998, 351 (9100) :417-418